UnitedHealth Group Incorporated (UNH) — Financial statements
Income statement, balance sheet, and cash flow for UnitedHealth Group Incorporated — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 447,567↑11.8% | 400,278↑7.7% | 371,622↑14.6% | 324,162↑12.7% | 287,597 | |
| Cost of Revenue | 364,650↑17.3% | 310,879↑10.8% | 280,664↑14.8% | 244,545↑12.2% | 217,945 | |
| Gross Profit | 82,917↓7.3% | 89,399↓1.7% | 90,958↑14.2% | 79,617↑14.3% | 69,652 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Expenses | 63,953↑12.0% | 57,112↓2.5% | 58,600↑14.5% | 51,182↑12.0% | 45,682 | |
| Operating Expenses | 63,953↑12.0% | 57,112↓2.5% | 58,600↑14.5% | 51,182↑12.0% | 45,682 | |
| Total Costs & Expenses | 428,603↑16.5% | 367,991↑8.5% | 339,264↑14.7% | 295,727↑12.2% | 263,627 | |
| Operating Results | ||||||
| Operating Income | 18,964↓41.3% | 32,287↓0.2% | 32,358↑13.8% | 28,435↑18.6% | 23,970 | |
| Depreciation & Amortization | 4,361↑6.4% | 4,099↑3.2% | 3,972↑16.8% | 3,400↑9.6% | 3,103 | |
| EBITDA | 23,060↓17.9% | 28,076↓22.7% | 36,330↑14.1% | 31,835↑17.6% | 27,073 | |
| EBIT | 18,699↓22.0% | 23,977↓25.9% | 32,358↑13.8% | 28,435↑18.6% | 23,970 | |
| Interest & Other Income | ||||||
| Net Interest Income | -4,002↓2.5% | -3,906↓20.3% | -3,246↓55.2% | -2,092↓26.0% | -1,660 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 4,002↑2.5% | 3,906↑20.3% | 3,246↑55.2% | 2,092↑26.0% | 1,660 | |
| Non-Operating Income | 265↓96.8% | 8,310 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | -4,267↑65.1% | -12,216↓276.3% | -3,246↓55.2% | -2,092↓26.0% | -1,660 | |
| Income Before Tax | 14,697↓26.8% | 20,071↓31.1% | 29,112↑10.5% | 26,343↑18.1% | 22,310 | |
| Income Tax Expense | 1,890↓60.9% | 4,829↓19.1% | 5,968↑4.6% | 5,704↑24.6% | 4,578 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 12,807↓16.0% | 15,242↓34.1% | 23,144↑12.1% | 20,639↑16.4% | 17,732 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 12,056↓16.3% | 14,405↓35.6% | 22,381↑11.2% | 20,120↑16.4% | 17,285 | |
| Bottom-Line Net Income | 12,056↓16.3% | 14,405↓35.6% | 22,381↑11.2% | 20,120↑16.4% | 17,285 | |
| EPS (Basic) | 13.23↓15.4% | 15.64↓35.2% | 24.12↑12.0% | 21.54↑17.5% | 18.33 | |
| EPS (Diluted) | 13.23↓14.7% | 15.51↓35.0% | 23.86↑12.7% | 21.18↑17.1% | 18.08 | |
| Weighted Average Shares | 910↓2.0% | 929↑0.1% | 928↓0.6% | 934↓1.0% | 943 | |
| Weighted Average Diluted Shares | 910↓2.0% | 929↓1.0% | 938↓1.3% | 950↓0.6% | 956 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.